Categories: Medical Fraud

Repackaged Zepbound? Lilly Says It’s Fraud—and Dangerous: DOWNSIZED NEWS



Latest GLP-1 News: Lawsuits, Industry Shifts, and Future Treatments

This episode of Downsized News, hosted by Laraine and Christopher Durham, delves into critical updates surrounding GLP-1 treatments. Key stories include Eli Lilly’s lawsuit against Premier Weight Loss for unsafe practices in repackaging Tirzepatide, Weight Watchers’ potential bankruptcy reflecting a shift from traditional diet methods to medical treatments like GLP-1, and Novo Nordisk’s $1 billion factory expansion in Brazil to meet growing global demand for medications like Ozempic and Wegovy. The show also explores Syntis Bio’s investigational oral obesity drug SYNT-101, utilizing a novel approach resembling gastric bypass surgery. Additionally, political developments include Robert F. Kennedy Jr. discussing potential Medicare and Medicaid coverage expansions for GLP-1 treatments and Senator John Fetterman advocating for better access based on personal success with Mounjaro. Compounding challenges are highlighted, with companies like Orderly Meds and Noom pushing back against FDA rules to maintain patient access to affordable treatments. The hosts emphasize the profound shift in obesity care towards effective medical treatments over traditional diet approaches, urging viewers to stay informed and consult healthcare professionals for safe and effective use of GLP-1 medications.

BOOK THE DOWNSIZED AT SEA CRUISE: https://thedownsized.org/downsized-at

DOWNSIZED WEBSITE: https://thedownsized.org/

DOWNSIZED GLP-1 COMPANION PRODUCT STORE: https://thedownsized.org/downsized-store

JOIN CLUB DOWNSIZED: @thedownsized

FOR SPONSORSHIPS, BRAND DEALS & COLLABS: https://thedownsized.org/contact/

00:00 Introduction: Major Headlines in GLP-1 World
00:21 Meet Your Hosts: Laraine and Christopher Durham
01:10 Story 1: Eli Lilly’s Lawsuit Against Premier Weight Loss
03:53 Story 2: Weight Watchers Faces Bankruptcy
08:05 Story 3: Novo Nordisk’s Billion-Dollar Expansion in Brazil
10:03 Story 4: Census Bio’s New Investigational Obesity Drug
13:28 Story 5: Political Moves to Expand GLP-1 Coverage
15:30 Story 6: Orderly Meds Defends Compounding Practices
17:04 Story 7: Senator John Fetterman on GLP-1 Impact
18:55 Story 8: Noom’s Fight for Affordable GLP-1s
23:08 Final Thoughts and Farewell

source

Corruption Buzz

Recent Posts

UK Christian Officer Barred from Policing Wins Settlement – Billy Graham Evangelistic Association

UK Christian Officer Barred from Policing Wins Settlement  Billy Graham Evangelistic Association Source link

5 hours ago

Shams and scams: How to make sure your charity dollars land in the right pocket | Here & Now – WBUR

Shams and scams: How to make sure your charity dollars land in the right pocket…

6 hours ago

“It's just another institutional cover-up.” Attorney speaks out on shooting of Poughkeepsie man – News12 | Westchester

“It's just another institutional cover-up.” Attorney speaks out on shooting of Poughkeepsie man  News12 | Westchester…

10 hours ago

The Wuhan cover-up unmasked: Connecting the dots after the Gabbard declassifications and U.S. Senate hearing – The Sunday Guardian

The Wuhan cover-up unmasked: Connecting the dots after the Gabbard declassifications and U.S. Senate hearing  The…

11 hours ago

Secretary of State Marco Rubio On Fox News Channel’s My View with Lara Trump

QUESTION:  Secretary, great to have you back.  Thank you so much. SECRETARY RUBIO:  Glad to…

13 hours ago

Italy arrests 9 suspected of funding Hamas via charities – South China Morning Post

Italy arrests 9 suspected of funding Hamas via charities  South China Morning Post Source link

17 hours ago